- Home
- GRI vs AEMD Comparison
GRI vs AEMD Comparison
Compare GRI & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- AEMD
- Stock Information
- Founded
- GRI 2018
- AEMD 1984
- Country
- GRI United States
- AEMD United States
- Employees
- GRI N/A
- AEMD N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- AEMD Medical/Dental Instruments
- Sector
- GRI Health Care
- AEMD Health Care
- Exchange
- GRI Nasdaq
- AEMD Nasdaq
- Market Cap
- GRI 5.6M
- AEMD 5.0M
- IPO Year
- GRI N/A
- AEMD N/A
- Fundamental
- Price
- GRI $0.42
- AEMD $0.58
- Analyst Decision
- GRI Strong Buy
- AEMD Strong Buy
- Analyst Count
- GRI 2
- AEMD 1
- Target Price
- GRI $11.50
- AEMD $7.00
- AVG Volume (30 Days)
- GRI 172.9K
- AEMD 717.6K
- Earning Date
- GRI 03-27-2025
- AEMD 02-12-2025
- Dividend Yield
- GRI N/A
- AEMD N/A
- EPS Growth
- GRI N/A
- AEMD N/A
- EPS
- GRI N/A
- AEMD N/A
- Revenue
- GRI N/A
- AEMD N/A
- Revenue This Year
- GRI N/A
- AEMD N/A
- Revenue Next Year
- GRI N/A
- AEMD N/A
- P/E Ratio
- GRI N/A
- AEMD N/A
- Revenue Growth
- GRI N/A
- AEMD N/A
- 52 Week Low
- GRI $0.30
- AEMD $0.24
- 52 Week High
- GRI $12.31
- AEMD $1.85
- Technical
- Relative Strength Index (RSI)
- GRI 28.18
- AEMD 41.29
- Support Level
- GRI $0.43
- AEMD $0.58
- Resistance Level
- GRI $0.60
- AEMD $0.67
- Average True Range (ATR)
- GRI 0.06
- AEMD 0.05
- MACD
- GRI -0.00
- AEMD -0.02
- Stochastic Oscillator
- GRI 10.91
- AEMD 1.55
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.